Hot issues
Take action!
Contact your legislators to stop fake online pharmacies and report social media drug sellers to the DEA
Follow us: Twitter | YouTube | Facebook | LinkedIn | Instagram
On March 14, the Partnership for Safe Medicines submitted comment on Customs and Border Protection’s proposed update to regulations around low-value, “de minimus” shipments.
A Texas man billed government programs millions for creams compounded by untrained teenagers. News about counterfeit medicine in six U.S. states.
FDA’s shutdown of GLP-1 compounding could lead to a new era of risk for U.S. patients.
The FDA published an update to a previous alert about undeclared active pharmaceutical ingredients in a dietary supplement to expand the package styles affected by this warning.
An FDA alert shared information on a nationwide recall of a nasal wash system due to microbrial contamination.
An FDA alert warned that Central Admixture Pharmacy Services issued a nationwide recall of Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag due to the detection of black particulate matter in a single sealed vial of Phenylephrine Hydrochloride.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
Why should fake drugs overseas matter to me? Watch.
Watch to learn who HSI arrested and why and keep track here.
The American Diabetes Association warned patients about non-FDA approved GLP-1 injections. Learn more.
Click the images below to see more recent videos.